Loading…
Back To Schedule
Tuesday, March 15 • 9:45am - 10:30am
Panel: Establish an Integrated and Optimized BD&L Process to Maximize the Value and Success of the Deal

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

  • Engaging the right team to ensure you get real cross functional feedback
  • Develop strategies to get the most out of your team during the entire BD&L process
  • Define the roles, responsibilities and efforts of each function during various parts of the lifecycle of the deal
  • How to identify and interact with the key decision-makers, including board members, to streamline the deal-making process
  • Making the difficult decision to kill an internal program in favor of a new product – what are the trade-offs?

Moderators
avatar for Ravi Kiron

Ravi Kiron

Head, BioPharma External Innovation, EMD Serono, Inc.
Dr. Ravi Kiron based in California, USA is an experienced pharma/biotech executive with decades of experience in discovery R&D through late-stage clinical development, intellectual property and regulatory, technology & business development, M&A, strategy and product commercialization... Read More →

Speakers
avatar for Neil Berkley

Neil Berkley

Chief Business Officer, AbCellera
Neil Berkley is Chief Business Officer at AbCellera. He has twenty plus years of corporate development, business development, and strategic planning experience in large pharma, midsize biotech/specialty pharma and small biotech companies. He has completed a wide variety of transactions... Read More →
avatar for Ariel Jasie

Ariel Jasie

Chief Business Officer, General Counsel, & Corporate Secretary, eGENESIS, INC.
Before eGenesis, Mr. Jasie most recently worked at Dermavant Sciences where he served as the chief business and strategy officer. At Dermavant, he initiated and led business development interactions for both in- and out-licensing efforts, as well as oversaw cross functional teams... Read More →
avatar for Ramlah Nehring, Ph.D.

Ramlah Nehring, Ph.D.

Head of Strategy and Transactions, Roche Diagnostics
Ramlah Nehring, Ph.D. is the Head of Strategy and Transactions at Roche Diagnostics, she is based in San Diego, California and leads a global team across APAC, North America and Europe. Her team leads deals for Roche Diagnostics across the spectrum of partnerships, licensing, and... Read More →


Tuesday March 15, 2022 9:45am - 10:30am PDT